20
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation

, , , , , , , , & show all
Pages 503-512 | Received 02 Jun 2010, Accepted 25 Oct 2010, Published online: 03 Dec 2010

References

  • Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation. 2004;109: 2826–31.
  • Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802–15.
  • Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, . Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:e17–24.
  • Doyle B, Sorajja P, Hynes B, Kumar AH, Araoz PA, Stalboerger PG, . Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17:941–51.
  • Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G, . Blood monocytes mimic endothelial progenitor cells. Stem Cells. 2006;24:357–67.
  • Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–21.
  • Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, . Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222–32.
  • Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M, . Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation. 2003;108:2839–42.
  • George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, . Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2005;25:2636–41.
  • Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, . Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet. 2004;363:751–6.
  • Mansour S, Vanderheyden M, De Bruyne B, Vandekerckhove B, Delrue L, Van Haute I, . Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol. 2006;47:1727–30.
  • Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, . Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112:I178–83.
  • Anami Y, Kobori S, Sakai M, Kasho M, Nishikawa T, Yano T, . Human beta-migrating very low density lipoprotein induces foam cell formation in human mesangial cells. Atherosclerosis. 1997;135:225–34.
  • Haust MD. Myogenic foam cells in explants of fatty dots and streaks from rabbit aorta. Morphological studies. Atherosclerosis. 1977;26:441–64.
  • Grande J, Davis HR, Bates S, Mathews MB, Glagov S. Effect of an elastin growth substrate on cholesteryl ester synthesis and foam cell formation by cultured aortic smooth muscle cells. Atherosclerosis. 1987;68:87–93.
  • Strunk D, Rohde E, Lanzer G, Linkesch W. Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy. Transfusion. 2005;45:315–26.
  • Bartmann C, Rohde E, Schallmoser K, Purstner P, Lanzer G, Linkesch W, . Two steps to functional mesenchymal stromal cells for clinical application. Transfusion. 2007;47:1426–35.
  • Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, . Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum Tissue Eng Part C Methods. 2008;14: 185–96.
  • Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, . Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood. 2009;113:6716–25.
  • Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, . Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009;27:2331–41.
  • Reinisch A, Strunk D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J Vis Exp. 2009;(32) doi: 103791/1525.
  • Schallmoser K, Strunk D. Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp. 2009;(32) doi: 103791/1523.
  • Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, . Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44:1690–9.
  • Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, . Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res. 2005;97: 756–62.
  • Basu SK, Goldstein JL, Anderson GW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 1976;73:3178–82.
  • Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G, . Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med. 2007;2:371–82.
  • Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, . Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells. 2007;25: 1746–52.
  • Farese RV, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell. 2009;139:855–60.
  • Zhao M, Liu Y, Wang X, New L, Han J, Brunk UT. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS. 2002;110:458–68.
  • Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37–40.
  • Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, . Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009–17.
  • Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, . Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1–7.
  • Buja LM, Kovanen PT, Bilheimer DW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol. 1979; 97:327–57.
  • Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RG. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82: 597–613.
  • Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, . Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med. 2010;16:470–4.
  • Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res. 2010;85:845–52.
  • Haust MD. The nature of bi- and trinuclear cells in atherosclerotic lesions in man Ultrastructural studies of aortic fatty dots and streaks. Atherosclerosis. 1980;36:365–77.
  • Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13:87–102.
  • Melero-Martin J, De Obaldia ME, Allen P, Dudley AC, Klagsbrun M, Bischoff J. Host myeloid cells are necessary for creating bio-engineered human vascular networks in vivo. Tissue Eng Part A. 2010:16(8):2457–66.
  • Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res. 2010;85: 649–60.
  • Huikuri HV, Kervinen K, Niemela M, Ylitalo K, Saily M, Koistinen P, . Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29: 2723–32.
  • Jiang S, Haider H, Idris NM, Salim A, Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res. 2006;99:776–84.
  • Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, . Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 2000;89:189–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.